Trademark: 85749420
Word
SANOVEL
Status
Dead
Status Code
710
Status Date
Friday, July 3, 2020
Serial Number
85749420
Registration Number
4438655
Registration Date
Tuesday, November 26, 2013
Mark Type
4000
Filing Date
Tuesday, October 9, 2012
Published for Opposition
Tuesday, September 10, 2013
Cancellation Date
Friday, July 3, 2020

Trademark Owner History

Classifications
5 pharmaceutical preparations for the treatment of cardiovascular disorders, skeleto-muscular disorders, general infections, viral infections, central nervous system disorders, gastro-intestinal disorders, fungal diseases, erectile dysfunction, respiratory diseases, allergy, ophthalmic diseases, containing one or more of the following active ingredients - cromolin sodium, amlodipin besylate, alendronate sodium, chlorazepate dipotassium, atropine sulphate, atorvastatin calcium, candesartan cilexetil, ceftriaxone sodium, ephedrine hcl, guaiphenesine, zafirlukast, donepezil hcl, diflunisal, dipyridamole, famotidine, losartan potassium, hydro-chlorothiazide, meloxicam, phenyleprine hcl, fexofenadine hcl, indapamide, sulfisoxazole, clopidogrel, lansoprazole, clarithromycin, flurbiprofen, nimesulide, pantoprazole, paracetamole, pilocarpine hcl, lisinopril, pseudoephedrine hcl, ciprofloxacin hcl, sertraline hcl, cyclopentolate hcl, dihydroergotoxine methansulfonate, terbinafine, timolol maleate, tiamphenicol, azithromycin, tenoxicam, fluconazole, digoxine, tioconazole, dimenhydrinate, quinidine arabogalactane sulphate, quinidine phenylethyl barbiturate, diltiazem hcl, buspirone hcl, amiodarone hcl, trazodone, difluprednate, enoxacin, lactulose, ketorolac, pentoxifylline, vitamin e, chlorhexidine, cetrimide, propyphenazone, caffeine, cetirizine, phenylpropanolamine, zolpidem, bacampicillin hcl, roxithromycin, sultamicillin tosilate, acetylsalicylic acid, ampicillin na, sulbactam na, sildenafil citrate, ambroxol hcl, ribavirin, loratadine, etodolac, omeprazole, oxybutynin chloride, quinidine sulphate, olanzapine, raloxifen, pioglitazone, moxifloxacin, rosiglitazone, sibutramin, carvedilol, montelukast, citalopram, gliclazide, cefaclor, ezetimibe, rofecoxib, quetiapine fumarate, metformin hcl, acarbose, chlorpheniramine maleate, nateglinide, leflunomide, valsartan, cefazolin sodium, diacerein, paroxetine, levofloxacin, levetiracetam, zolmitriptan, glibenclamide, tizanidine, perindopril erbumine, ramipril, ceftazidime, cefuroxime axetyl, thiocolchicoside, acamprosate, acetylcysteine, alpha calcidol, alpha lipoic acid, aripiprazole, atomoxetine, balsalazide disodium, butenafine hcl, calcitriol, carbonyl iron, folic acid, calcium carbonate, magnesium hydroxide, cefdinir, cefepime hcl, cefixime, cefpodoxime proxetil, cefprozil, cephalexine monohydrate, ciclesonide, cilazapril, cilostazol, cinitapride, citicoline, co-enzyme q10, darifenasin, deferiprone, dothiepin, duloxetine, eletriptan, escitalopram, esomeprazole, etoricoxib, felodipine, fenofibrate, ferrous sulphate, zinc sulphate, fluvastatin, frovatriptan, gabapentin, galantamine, gemifloxacin, ginkgo biloba, glimepride, granisetron, ibandronate, irbesartan, iron hydroxide polymaltose, lamivudine, lamotrigine, levetiracetam, letrozole, linezolide, memantine hcl, metoprolol, midodrine, mirtazapine, mizolastine, mosapride citrate dihydrate, mycophenolate mofetil, nebivolol, nefazodone, niacin, nitazoxanide, ondansetron, ornidazole, oxcarbazepine, pimecrolimus, pravastatin, pregabalin, rabeprazol, rebamipide, repaglinide, risedronate, risperidone, rivastigmine, rosuvastatin, saccharomyces boulardii, tacrolimus, tadalafil, tamsulosin hcl, tazaroten, tazobactam sodium, piperacillin sodium, tegaserod, telithromycin, terazocin, teriparatide, tolterodine tartrate, topiramate, trandolapril, trimethazidine, valacyclovir, valproate sodium, venlafaxine, voriconazole, ximelagatran, zaleplon, ziprasidone, zoledronic acid
Color is not claimed as a feature of the mark.

Trademark Events
Jul 3, 2020
Cancelled Sec. 8 (6-Yr)
Nov 26, 2018
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 26, 2013
Registered-Principal Register
Sep 10, 2013
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2013
Published For Opposition
Aug 21, 2013
Notification Of Notice Of Publication E-Mailed
Aug 7, 2013
Law Office Publication Review Completed
Aug 6, 2013
Approved For Pub - Principal Register
Aug 6, 2013
Amendment From Applicant Entered
Aug 6, 2013
Correspondence Received In Law Office
Aug 1, 2013
Paper Received
Feb 7, 2013
Combined Examiner's Amendment/Priority Action Entered
Feb 6, 2013
Assigned To Lie
Feb 6, 2013
Notification Of Examiner's Amendment/Priority Action E-Mailed
Feb 6, 2013
Examiner's Amendment/Priority Action E-Mailed
Feb 6, 2013
Examiners Amendment And/Or Priority Action - Completed
Feb 6, 2013
Assigned To Examiner
Dec 11, 2012
Teas Change Of Correspondence Received
Oct 16, 2012
New Application Office Supplied Data Entered In Tram
Oct 12, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24